Literature DB >> 478641

Efficacy of antimicrobial therapy in experimental rat pneumonia: antibiotic treatment schedules in rats with impaired phagocytosis.

I A Bakker-Woudenberg, A L van Gerwen, M F Michel.   

Abstract

Pneumococcal pneumonia in rats with intact host defense mechanisms could be successfully cured by penicillin. The efficacy of this antibiotic therapy was lost in cobra venom factor-treated rats which had selectively impaired phagocytic functions. In these animals the effect of penicillin therapy was improved by increasing the daily dose and the frequency of injections and by earlier initiation of the therapy. The efficacy of penicillin in the cobra venom facttor-treated rats was restored either by markedly increasing the daily dose of penicillin or by increasing the daily dose in combination with a reduced interval of the penicillin injections.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 478641      PMCID: PMC414462          DOI: 10.1128/iai.25.1.376-387.1979

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  12 in total

1.  The influence of the dosage regimen on the therapeutic effectiveness of penicillin G in experimental lobar pneumonia.

Authors:  L H SCHMIDT; A WALLEY
Journal:  J Pharmacol Exp Ther       Date:  1951-12       Impact factor: 4.030

2.  Antibiotic combinations for infections in neutropenic patients. Evaluaton of carbenicillin plus either cephalothin or kanamycin.

Authors:  E L Middleman; A Watanabe; H Kaizer; G P Bodey
Journal:  Cancer       Date:  1972-08       Impact factor: 6.860

3.  Simplified, accurate method for antibiotic assay of clinical specimens.

Authors:  J V Bennett; J L Brodie; E J Benner; W M Kirby
Journal:  Appl Microbiol       Date:  1966-03

4.  Optimal antibiotic therapy for infections in patients with cancer: prospects for the future.

Authors:  J Klastersky; M Staquet
Journal:  Eur J Cancer       Date:  1973-06       Impact factor: 9.162

5.  High-dose penicillin therapy and pneumococcal pneumonia.

Authors:  A Brewin; L Arango; W K Hadley; J F Murray
Journal:  JAMA       Date:  1974-10-21       Impact factor: 56.272

6.  Synergistic activity of carbenicillin and gentamicin in experimental Pseudomonas bacteremia in neutropenic rats.

Authors:  R E Scott; H G Robson
Journal:  Antimicrob Agents Chemother       Date:  1976-10       Impact factor: 5.191

7.  Ticarcillin in combination with cephalothin or gentamicin as empiric antibiotic therapy in granulocytopenic cancer patients.

Authors:  S C Schimpff; S Landesman; D M Hahn; H C Standiford; C L Fortner; V M Young; P H Wiernik
Journal:  Antimicrob Agents Chemother       Date:  1976-11       Impact factor: 5.191

8.  Amikacin and cephalothin: empiric regimen for granulocytopenic cancer patients.

Authors:  D M Hahn; S C Schimpff; V M Young; C L Fortner; H C Standiford; P H Wiernik
Journal:  Antimicrob Agents Chemother       Date:  1977-11       Impact factor: 5.191

9.  Gram-negative bacillary infections in cancer patients.

Authors:  G P Bodey; V Rodriguez; M Valdivieso; M Keating
Journal:  S Afr Med J       Date:  1977-12-17

10.  Efficacy of antimicrobial therapy in experimental rat pneumonia: effects of impaired phagocytosis.

Authors:  I A Bakker-Woudenberg; J Y de Jong-Hoenderop; M F Michel
Journal:  Infect Immun       Date:  1979-07       Impact factor: 3.441

View more
  1 in total

1.  Efficacy of antimicrobial therapy in experimental rat pneumonia: effects of impaired phagocytosis.

Authors:  I A Bakker-Woudenberg; J Y de Jong-Hoenderop; M F Michel
Journal:  Infect Immun       Date:  1979-07       Impact factor: 3.441

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.